Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017

Details for Mechanism ID: 17600
Country/Region: Indonesia
Year: 2017
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $4,976,794 Additional Pipeline Funding: $284,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $561,094
Strategic Information (HVSI) $472,500
Health Systems Strengthening (OHSS) $77,500
Testing: HIV Testing and Counseling (HVCT) $489,000
Sexual Prevention: Other Sexual Prevention (HVOP) $1,507,250
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $72,000
Treatment: Adult Treatment (HTXS) $1,797,450
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 34,079
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 27,860
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Female, Negative 2018 308
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Male, Negative 2018 2,395
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 12,938
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 15,032
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 172
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 720
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 7,961
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 15,879
HTS_TST Sum of Test Result disaggregates 2018 3,406
HTS_TST Sum of Test Result disaggregates 2018 3,128
HTS_TST_POS By Test Result: Positive 2018 3,406
HTS_TST_POS By Test Result: Positive 2018 3,128
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Female, Positive 2018 31
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Male, Positive 2018 188
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 1,516
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 1,671
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 86
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 976
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 2,045
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 4,953
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 6,192
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 269
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 2,423
KP_PREV By key population type: Men who have sex with men and are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 1,238
KP_PREV By key population type: Men who have sex with men and are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 18,571
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 269
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 13,462
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 269
KP_PREV By key population type: Transgender who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 4,038
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 24,762
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 26,922
TX_CURR Aggregated Age/Sex: <15 Female 2018 65
TX_CURR Aggregated Age/Sex: <15 Female 2018 34
TX_CURR Aggregated Age/Sex: <15 Male 2018 65
TX_CURR Aggregated Age/Sex: <15 Male 2018 84
TX_CURR Aggregated Age/Sex: 15+ Female 2018 3,195
TX_CURR Aggregated Age/Sex: 15+ Female 2018 1,606
TX_CURR Aggregated Age/Sex: 15+ Male 2018 3,196
TX_CURR Aggregated Age/Sex: 15+ Male 2018 3,980
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 6,521
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 5,704
TX_CURR Sum of Aggregated Age/Sex <15 2018 130
TX_CURR Sum of Aggregated Age/Sex <15 2018 118
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 6,391
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 5,586
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 6,521
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 5,704
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 32
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 26
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 32
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 48
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 1,581
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 1,160
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,585
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 2,224
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,230
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,458
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 3,230
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 3,458
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 626
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 696
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 384
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 418
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 4
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 188
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 84
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 192
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 328
TX_PVLS Numerator: Indication: Routine 2018 384
TX_PVLS Numerator: Indication: Routine 2018 418
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 13
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 13
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 11
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 296
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 142
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 304
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 540
TX_PVLS_den Denominator: Indication: Routine 2018 626
TX_PVLS_den Denominator: Indication: Routine 2018 647
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 11
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 8
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 11
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 28
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 556
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 465
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 558
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,414
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,136
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,915
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 1,420
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 2,206
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 14
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 10
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 14
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 32
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 693
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 583
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 699
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,581
Cross Cutting Budget Categories and Known Amounts Total: $5,880,000
Key Populations: MSM and TG $2,100,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $1,500,000
Training of health workers and community outreach workers
Monitoring and evaluation of SW programs
Gender: Gender Based Violence (GBV) $780,000
GBV Prevention
Operation Research
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $500,000
Promoting gender-related policies and laws that increase legal protection
Condoms: Policy, Tools, and Services $1,000,000